BURLINGTON, Mass., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, today announced that Dr. Bobby W. Sandage, Jr., Coronado’s President and CEO, will present at the at the Leerink Swann 2012 Global Healthcare Conference on Wednesday, February 15, 2012, at 12:00 PM ET. The conference will be held at the Waldorf Astoria Hotel in New York City.
